Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 25, 2024 08:30 ET | Source: Eterna Therapeutics

Eterna Therapeutics Announces Up to $1 Million Stock Repurchase Program

Eterna Therapeutics Announces $1 Million Stock Repurchase Program
October 17, 2024 08:00 ET | Source: Eterna Therapeutics

Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases

CAMBRIDGE, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”) and Factor Bioscience Limited (“Factor”) today announced an exclusive license...